Bizarre Patents
User-operated amusement apparatus for kicking the user's buttocks
An apparatus including a user-operated and controlled apparatus for self-infliction of repetitive blows to the user's buttocks by a plurality of elongated arms bearing flexible extensions that rotate under the user's control.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7868181 | Compounds The present invention relates to new compounds of formula I, where R1 and R2 are independently halo or C1-3haloalkyl, X is ethenyl or ethynyl, or a salt thereof.... | 01/11/2011 |
| 7329759 | Illudin analogs useful as antitumor agents The present invention provides illudin analogs of the general formula (I): where R1 is (CH2)n—X—Y or H; n is 0 to 4; X is O or S or N or absent; and Y... | 02/12/2008 |
| 7309787 | Kinase inhibitors The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation. ... | 12/18/2007 |
| 7288559 | Carboxamide spirohydantoin CGRP receptor antagonists The present invention is directed to compounds that are antagonists of CGRP receptors and that are useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pha... | 10/30/2007 |
| 7220866 | Imidazolic compounds and use thereof as alpha-2-adrenergic receptors The invention provides compounds having the formula (1): wherein R1 is hydrogen, fluoro or methoxyl, R1 being in position 2, 3, 4 or 5 of the aromatic carbocycle; R2 is hydrogen or methyl; R3 is hydrogen, methyl ... | 05/22/2007 |
| 7202251 | Bicyclic anilide spirohydantoin CGRP receptor antagonists The present invention is directed to compounds of the formula: that are antagonists of CGRP receptors and that are useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache... | 04/10/2007 |
| 7189722 | Aryl spirohydantoin CGRP receptor antagonists The present invention is directed to compounds that are antagonists of CGRP receptors and that are useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pha... | 03/13/2007 |
| 7166611 | Pharmaceutical compositions having appetite suppressant activity A pharmaceutical composition contains an extract obtainable from a plant of the genus Trichocaulon or Hoodia containing an appetite suppressant agent having the formula (1). A process for obtaining the extract and a process for synthesizing compound (1... | 01/23/2007 |
| 7084208 | N-halamine vinyl compounds and their polymeric biocides The present invention provides heterocyclic vinylic compounds that can be used to form biocidal polymers. The polymers thus generated can used alone or can be grafted onto textiles, fabrics and polymers. The polymers are readily converted to N-halamine structures on... | 08/01/2006 |
| 7019148 | Synthesis of irbesartan Provided are a method of making irbesartan via a Suzuki coupling reaction and a novel intermediate, 2-butyl-3-(4′-bromobenzyl)-1,3-diazaspiro[4.4]non-1-ene-4-one, for such process. The novel process includes the step of reacting such intermediate with a protected ... | 03/28/2006 |
| 7014781 | Methods and articles for maintaining hydantoinylated polymers in a biocidally active state A composition and the method for sustaining the biocidal activity of chlorinated polystyrene hydantoin beads. The method comprises supplying a continuous low level halogen concentration to the chlorinated polystyrene hydantoin beads in the water to be treated that f... | 03/21/2006 |
| 6919364 | Microbiological control in animal processing Fecal bacterial contamination in an animal is reduced by providing it with drinking water containing a microbiocidally-effective amount of halogen-based microbiocide resulting from mixing with water (A) a product formed in water from (i) bromine, chlorine, or bromin... | 07/19/2005 |
| 6908636 | Microbiological control in poultry processing In the processing of poultry, equipment, instruments, apparatus and/or water used in such processing, and/or carcasses and/or parts of poultry resulting from the processing of poultry, are disinfected with aqueous solutions of certain halogen-based microbiocides, es... | 06/21/2005 |
| 6768009 | N-halamine vinyl compounds and their polymeric biocides The present invention provides heterocyclic vinylic compounds that can be used to form biocidal polymers. The polymers thus generated can used alone or can be grafted onto textiles, fabrics and polymers. The polymers are readily converted to N-halamine structures on... | 07/27/2004 |
| 6500958 | Carboxylic acid derivatives and process for producing the same The present invention relates to compounds which are useful for efficient synthesis of 2-amino-4-oxobicyclo[3.1.0]hexane-2,6-dicarboxylic acids. The compounds according to the present invention comprise 2-oxobicyclo[3.1.0]hexane-6-carboxylic acid derivatives r... | 12/31/2002 |
| 6316437 | Spirohydantoin compounds and uses thereof Spirohydantoin compounds and their pharmaceutically acceptable salts are disclosed. The synthesis of these compounds and their use as alpha 1a adrenergic receptor antagonists is also described. One application of these compounds is in the treatment of ben... | 11/13/2001 |
| 6191160 | Spiro-indolines as Y5 receptor antagonists Compounds of the general structural formula I ##STR1## are selective NPY Y5 receptor antagonists. The compounds and compositions of the present invention are useful in the treatment of obesity and complications associated therewith.... | 02/20/2001 |
| 6172097 | Spiro imidazoline compounds The invention relates to a compound of formula (I): ##STR1## wherein: A represents an optionally substituted benzene ring, B represents an imidazoline ring of formula (Ia) or (Ib): ##STR2## and medicinal products containing the same/are useful in treating or i... | 01/09/2001 |
| 6124463 | Benzimidazoles as corticotropin release factor antagonists The present invention describes novel benzimidazoles of formula: ##STR1## or pharmaceutically acceptable salt forms thereof, which are useful as CRF antagonists.... | 09/26/2000 |
| 5958960 | Excitatory amino acid receptor modulators Compounds of the formula ##STR1## in which R1 and R2 are as defined in the specification, and non-toxic metabolically labile ester and amides thereof are useful as modulators of metabotropic glutamate receptor function.... | 09/28/1999 |
| 5670646 | Monomeric and polymeric cyclic amine and-halamine compounds Cyclic amine monomers and polymers and N-halamine biocidal polymer compounds are provided. Methods of making and using the same wherein the functional groups unhalogenated or halogenated hydantoins, triazine diones, imidazolidinones, and pyrimidinones are... | 09/23/1997 |
| 5648374 | Benzospiroalkene compounds Compounds of formula (I): ##STR1## in which: X represents --CH2 --, --(CH2)2 --, --CH.dbd.CH--, --O--CH2 --, --S--CH2 --, --SO--CH2 -- or --SO2 --CH2 --, Y repres... | 07/15/1997 |
| 5591848 | Spiroconjugated charge-transfer dyes for optical applications New intramolecular charge-transfer organic dyes are described. The design of these molecules is based on the phenomenon of spiroconjugation, and it provides a modular approach to the preparation of unique materials with interesting optical properties. In ... | 01/07/1997 |
| 5559233 | Methods for preparing n-substituted heterocyclic derivatives The invention relates to processes for preparing N-substituted heterocyclic compounds of formula (I) ##STR1##... | 09/24/1996 |
| 5534536 | Fused phenol derivatives Fused phenol compounds of the formula (I): ##STR1## (wherein R1 and R2 each, independently, is H, halogen, trifluoromethyl, cyano, (substituted) alkyl, alkoxy, cycloalkyl, COOH, COOR6 (in which R6 is C1-6 a... | 07/09/1996 |
| 5464859 | Benzospiroalkene derivatives Compounds of formula (I): ##STR1## wherein: --X represents --CH2 --, --(CH2)2 --, --CH.dbd.CH--, --O--CH2 --, --S--CH2 --, --SO--CH2 -- or --SO2 --CH2 --, --R | 11/07/1995 |
| 5447946 | Hydantoin derivatives for treating complications of diabetes Hydantoin derivatives and salts thereof, intermediates therefor, process for the preparation thereof, and medicines containing the derivative, wherein said derivatives have the formula ##STR1## wherein one of V and W is hydrogen and the other is a ha... | 09/05/1995 |
| 5436261 | Benzospiroalkene heterocyclic compounds Compounds of formula (I): ##STR1## in which: X represents --CH2 --, --(CH2)2 --, --CH.dbd.CH--, --O--CH2 --, --S--CH2 --, --SO--CH2 -- or --SO2 --CH2 --, Y repres... | 07/25/1995 |
| 5430048 | Spirocyclic benzopyran imidazolines Spiro- [4H- 1 -benzopyran-4,4'-5'H-imidazol]-5'-ones of the Formula 1: ##STR1## wherein R1 is H, R2 F, Cl, Br, CF3, CF3 O, CN, NO2, R2 SO2, R2 NHSO2, R... | 07/04/1995 |
| 5329006 | Chromogenic lactam compounds, their preparation and their use Chromogenic lactam compounds of the formula ##STR1## in which the ring A is an aromatic or heteroaromatic radical which has 6 ring atoms and may contain a fused aromatic ring, it being possible for both the ring A and the fused ring to be substituted... | 07/12/1994 |
| 5274104 | N-substituted heterocyclic derivatives useful in the treatment of cardiovascular disorders The present invention relates to N-substituted heterocyclic derivatives of formula: ##STR1## processes for their preparation, and pharmaceutical compositions which contain them. The compounds according to the invention are non-peptide compounds ... | 12/28/1993 |
| 5270317 | N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present The invention relates to N-substituted heterocyclic derivatives and its salts. These derivatives have the formula ##STR1## in which the substituents are as defined in the specification. Application: Angiotensin II antagonists... | 12/14/1993 |
| 5212186 | Cardioactive pyrrolobenzimidazoles Compounds for the treatment of cardiac insufficiency, an arterial thrombo embolism, an arterial occlusive disease, psoriasis, neurodermatitis, asthma, platelet aggregation and hypertension, of the formula ##STR1## in which R1 is hydrogen, ... | 05/18/1993 |
| 5211736 | Azole derivatives of spiroheterocycles A compound having the structural formula ##STR1## where R is C2 -C8 alkylene having 2 to 4 carbon atoms linking X and Y; R1 is C1 -C8 linear or branched alkylene, C1 -C6 oxyalkylene, ... | 05/18/1993 |
| 5182289 | Heterobicyclic compounds having antiinflammatory activity Heterobicyclic and heterocyclic intermediate compounds and their use in treating inflammation, hyperproliferative skin conditions such as psoriasis and allergy are disclosed.... | 01/26/1993 |
| 5180825 | Mitomycin derivatives Disclosed in a mitomycin derivative represented by the formula (I): ##STR1## wherein W is a heterocyclic group.... | 01/19/1993 |
| 5180419 | Herbicidal 2-(2-imidazolin-2-yl)-benzo-(5-membered)-heterocycles and the use thereof There are provided o-carboxy-(5-oxo-2-imidazolin-2-yl)benzo-(5-membered)-heterocyclic compounds and derivatives thereof and a method for the use therewith to control monocotyledenous and dicotyledenous plant species.... | 01/19/1993 |
| 5164391 | Hydantoin derivatives for treating complications of diabetes and circulatory diseases The invention relates to a hydantoin derivative, salt thereof, process for the preparation thereof, and medicine containing the derivative. The derivative is represented by the formula ##STR1## wherein M is --CONH--NHR1 group, --CONH--OR | 11/17/1992 |
| 5140031 | Pyranyl cyanoguanidine derivatives Novel compounds having the formula ##STR1## wherein ##STR2## are disclosed. These compounds have potassium channel activating activity and are useful, for example, as cardiovascular agents, especially as antiischemic agents.... | 08/18/1992 |
| 5108485 | Herbicidal 2-(2-imidazolin-2-yl)-benzazoles There are provided o-carboxy-(5-oxo-2-imidazolin-2-yl)benzoheterocyclic compounds wherein the fused heterocyclic ring system is a 5-membered ring containing one, two or three nitrogen atoms, derivatives of said benzoheterocyclic compounds and a method for... | 04/28/1992 |
